Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Ruben Minski
Introduction
Ruben Minski is a notable inventor based in Barranquilla, Colombia. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cholesterol regulation. His work has implications for treating various disorders related to elevated serum cholesterol levels.
Latest Patents
Minski holds a patent for "Compositions containing HMG Co-A reductase inhibitors and policosanol." This invention provides pharmaceutical compositions, methods, combinations, and kits aimed at treating disorders such as hypercholesterolemia, atherosclerosis, and hypertension. The compositions include atherapeutically effective amounts of lipid-regulating agents, specifically HMG-CoA reductase inhibitors, and compounds that inhibit cholesterol synthesis. A typical composition features atorvastatin and policosanol, which work together to manage cholesterol levels effectively.
Career Highlights
Minski's career is marked by his dedication to pharmaceutical innovation. His work at Procaps S.A. has allowed him to focus on developing effective treatments for cholesterol-related disorders. His patent reflects his commitment to improving health outcomes through scientific research and innovation.
Collaborations
Minski has collaborated with notable individuals in his field, including Isaac Angres and Meyer Minski. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Ruben Minski's contributions to pharmaceutical science, particularly in cholesterol management, highlight his role as an innovative inventor. His patent demonstrates the potential for effective treatments that can significantly impact public health.